1. Home
  2. NRDY vs GNLX Comparison

NRDY vs GNLX Comparison

Compare NRDY & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nerdy Inc.

NRDY

Nerdy Inc.

N/A

Current Price

$10.33

Market Cap

114.0M

Sector

Technology

ML Signal

N/A

Logo Genelux Corporation

GNLX

Genelux Corporation

N/A

Current Price

$2.72

Market Cap

123.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NRDY
GNLX
Founded
2007
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
123.1M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
NRDY
GNLX
Price
$10.33
$2.72
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$1.00
$17.25
AVG Volume (30 Days)
421.5K
319.0K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
13.16
9.47
EPS
N/A
N/A
Revenue
N/A
$8,000.00
Revenue This Year
$4.88
N/A
Revenue Next Year
$10.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$2.29
52 Week High
$11.03
$8.54

Technical Indicators

Market Signals
Indicator
NRDY
GNLX
Relative Strength Index (RSI) 92.92 49.99
Support Level $0.83 $2.71
Resistance Level N/A $2.98
Average True Range (ATR) 0.29 0.18
MACD 1.12 0.01
Stochastic Oscillator 92.44 84.38

Price Performance

Historical Comparison
NRDY
GNLX

About NRDY Nerdy Inc.

Nerdy Inc operate a next-generation live tutoring and intervention platform that leverages the power of human expertise with Developed artificial intelligence (AI) to personalize learning, accelerate student achievement, and empower educators. The company's proprietary platform leverages technology, including AI, to connect learners with instructors across a wide range of subjects and formats, including subscription-based learning, one-on-one instruction, small group tutoring, large-format classes, and assessments. Its flagship business operates under the Varsity Tutors brand. The company's offerings are available directly to students and consumers, as well as through schools and other institutions.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: